KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Net Margin (2016 - 2026)

Globus Medical filings provide 15 years of Net Margin readings, the most recent being 17.01% for Q4 2025.

  • On a quarterly basis, Net Margin rose 1298.0% to 17.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 18.3%, a 1422.0% increase, with the full-year FY2025 number at 18.3%, up 1421.0% from a year prior.
  • Net Margin hit 17.01% in Q4 2025 for Globus Medical, up from 15.47% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 27.22% in Q2 2025 to a low of 1.18% in Q1 2024.
  • Median Net Margin over the past 5 years was 16.53% (2021), compared with a mean of 13.46%.
  • The widest YoY moves for Net Margin: up 3054bps in 2021, down -2707bps in 2021.
  • Globus Medical's Net Margin stood at 7.81% in 2021, then soared by 153bps to 19.78% in 2022, then crashed by -88bps to 2.44% in 2023, then soared by 65bps to 4.03% in 2024, then skyrocketed by 322bps to 17.01% in 2025.
  • The last three reported values for Net Margin were 17.01% (Q4 2025), 15.47% (Q3 2025), and 27.22% (Q2 2025) per Business Quant data.